| Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre CL Shields, Z Bas, S Tadepalli, LA Dalvin, R Rao, R Schwendeman, ... British Journal of Ophthalmology 104 (11), 1548-1555, 2020 | 56 | 2020 |
| Adding the cancer Genome Atlas chromosome classes to American joint committee on cancer system offers more precise prognostication in uveal melanoma MC Gelmi, Z Bas, K Malkani, A Ganguly, CL Shields, MJ Jager Ophthalmology 129 (4), 431-437, 2022 | 33 | 2022 |
| Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases JAS Carol L Shields, Eileen L Mayro, Zeynep Bas, Philip W Dockery, Antonio ... Indian Journal of Ophthalmology 69 (7), 1839-1845, 2021 | 26 | 2021 |
| Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact CL Shields, Z Bas, A Laiton, AM Velasco Silva, AS Sheikh, SL Lally, ... Eye, 2022 | 25 | 2022 |
| Chromosome 3 and 8q aberrations in uveal melanoma show greater impact on survival in patients with light iris versus dark iris color APA Wierenga, NJ Brouwer, MC Gelmi, RM Verdijk, MH Stern, Z Bas, ... Ophthalmology 129 (4), 421-430, 2022 | 21 | 2022 |
| Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Z Baş, J Sharpe, A Yaghy, Q Zhang, CL Shields, L Hyman, AY Lee, ... Ophthalmology Science 3 (1), 100227, 2023 | 17 | 2023 |
| Risk factors for tumor recurrence following primary intravenous chemotherapy (chemoreduction) for retinoblastoma in 869 eyes of 551 patients LA Dalvin, Z Bas, S Tadepalli, R Rao, S Vaidya, R Pacheco, CL Shields Journal of Pediatric Ophthalmology & Strabismus 57 (4), 224-234, 2020 | 14 | 2020 |
| Sutureless Amniotic Membrane Transplantation in a Pediatric Patient with Acute Toxic Epidermal Necrolysis Z Baş, Ö Uçakhan Gündüz Turk J Ophthalmol 49 (6), 356-360, 2019 | 8 | 2019 |
| Characteristics of Uveitic Glaucoma in Turkish Patients O Tekeli, A Bayer, U Elgin, O Kemer, T Takmaz, A Karakurt, Z Bas European Glaucoma Society, 2016 | 8* | 2016 |
| Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (simplified version) in 1001 cases CL Shields, PW Dockery, EL Mayro, Z Bas, A Yaghy, SE Lally, M Orloff, ... Saudi Journal of Ophthalmology 36 (3), 308-314, 2022 | 7 | 2022 |
| Outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma based on patient age in 964 eyes of 554 patients Z Bas, LA Dalvin, S Tadepalli, R Rao, A Shah, AM Leahey, CL Shields Asia-Pacific Journal of Ophthalmology 10 (4), 373-380, 2021 | 7 | 2021 |
| Conjunctival melanoma in 430 cases: comparative analysis of the impact of orbital invasion on tumor recurrence, metastasis, and death Z Bas, PW Dockery, SE Lally, JA Shields, CL Shields Ophthalmic Plastic & Reconstructive Surgery 39 (1), 49-57, 2023 | 4 | 2023 |
| Aqueous flare as an indicator of response to Dexamethasone treatment in retinal vein occlusions: a pilot study S Demirel, Ö Yanık, F Batıoğlu, E Özmert, Z Baş Current Eye Research 41 (5), 700-707, 2016 | 4 | 2016 |
| The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes Z Bas, JM Grant-Kels, CL Shields Clinics in Dermatology 42 (1), 56-61, 2024 | 3 | 2024 |
| SARCOID GRANULOMA OF THE CHOROID AND CILIARY BODY IN 50 CASES Z Bas, Z Sajjadi, C Shields Retina 43 (11), 1842-1851, 2023 | 3 | 2023 |
| Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age CL Shields, A Samuelson, GJ Oh, ZL DeSimone, Joseph D, Sajjadi, Z Bas Invest Ophthalmol Vis Sci 64 (10), 7, 2023 | 3 | 2023 |
| Severe dry eye in CD25 deficiency syndrome Z Baş, BN Bayraktutar, ÖÖ Uçakhan Eye & Contact Lens 44 (1), e1-e3, 2018 | 3 | 2018 |
| Effectiveness of treatment for iris melanoma: Surgical versus radiotherapeutic approaches PW Dockery, JD DeSimone, CK Liu, K Achuck, J Hamburger, Z Bas, ... Canadian Journal of Ophthalmology 59 (5), 329-334, 2024 | 2 | 2024 |
| High local control and low ocular toxicity using ultra-low-dose “boom-boom” radiotherapy for indolent orbital lymphoma S Shelukar, C Fernandez, Z Bas, L Komarnicky, SE Lally, CL Shields, ... Chinese Clinical Oncology 11 (6), 44-50, 2022 | 2 | 2022 |
| Kontakt Lens Kullanımı ile İlişkili Kuru Göz ÖU GÜNDÜZ, ADZ BAŞ MN Oftalmoloji 23 (Suppl 1), 83-90, 2016 | 2 | 2016 |
Antonio YaghyDepartment of Ophthalmology and Visual Sciences, University of Massachusetts Chan Medical School在 umassmed.edu 的电子邮件经过验证
